The Erie County Law Enforcement Foundation elected Sam Palmiere chairman of its board of directors. Other officers: co-chairman, Mike Bryant; secretary, Chris Clark; and treasurer, Rob Vogel. Directors: Bill Loecher, of the West Herr Automotive Group, Kathy Mehltretter, Peter Casilio, Patrick Curley, Jon Dandes, Bill Zenosky, Peter Banks, Christopher Cummings, Kathleen Chubb, John Glascott, Thomas Higgins, Timothy Howard, William Mariani, Arthur Mussara, Daniel Penberthy, Edward Qualey, James Roberston, Mark Sullivan, Daniel Tauriello, Charles Tomaszewski and Peter Vito.
Hodgson Russ partner Carol A. Fitzsimmons presented “Cross-Border Planning: Tax Traps and Mismatches” recently at the Society of Trust and Estate Practitioners Canada conference in Toronto.
Dunkin’ Brands Group, the parent company of Dunkin’ Donuts and Baskin-Robbins, appointed Jeff Miller, a Buffalo native, executive chef and vice president of product innovation. Miller will head a 22-person culinary team to create new and unique food and beverages.
Impacto Consulting Associates recently launched its website at www.icanortheast.com, detailing its services to the Buffalo real estate industry.
Northrop Grumman Amherst Systems, Buffalo, was awarded a $2,917,028 federal contract for software maintenance and support from the U.S. Air Force Materiel Command, Hill Air Force Base, Utah.
Luminescent Systems, East Aurora, was awarded a $29,100 federal contract for various aircraft accessories and components from the U.S. Army Contracting Command, Redstone Arsenal, Ala.
Tim Hortons Cafe & Bake Shops Western New York presented a $20,664 check to the WNY Heroes recently. Proceeds from the WNY Heroes Donut campaign will provide financial assistance to returning service men and women in need.
Title: Peptide-peptidase inhibitor conjugates and methods of using same
Inventors: Ghosh, Soumitra S. (San Diego); Alfaro-Lopez, Josue (San Diego); D’Souza, Lawrence J. (San Diego); Levy, Odile Esther (San Diego); Lin, Qing (Buffalo); Soares, Christopher J. (San Diego)
Assignee: Amylin Pharmaceuticals (San Diego); Astrazeneca Pharmaceuticals (Wilmington, Del.)
Date issued: June 24, 2014